Evidence map›Paper›PMID 41901359›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Pharmacogenetic Associations with Statin Regimen Modification, Intolerance, and Adverse Outcomes in Coronary Artery Disease Patients.

Rania Abdel-Latif, Shaban Mohammed, Mohamad Saad, Khalid Kunji, Wadha Al-Muftah, Ayman El-Menyar, Jassim Al Suwaidi

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Rania Abdel-LatifQatar Genome Program, Qatar Precision Health Institute, Qatar Foundation, Doha 5825, Qatar.ORCID 0000-0002-3770-7128
Shaban MohammedPharmacy Department, Hamad Medical Corporation, Doha 3050, Qatar.
Mohamad SaadQatar Computing Research Institute, Hamad Bin Khalifa University, Doha 5825, Qatar.
Khalid KunjiQatar Computing Research Institute, Hamad Bin Khalifa University, Doha 5825, Qatar.
Wadha Al-MuftahQatar Genome Program, Qatar Precision Health Institute, Qatar Foundation, Doha 5825, Qatar.ORCID 0000-0003-2549-082X
Ayman El-MenyarTrauma and Vascular Research and Development, Hamad Medical Corporation, Doha 3050, Qatar.ORCID 0000-0003-2584-953X
Jassim Al SuwaidiCardiology and Cardiovascular Surgery, Hamad Medical Corporation, Doha 3050, Qatar.ORCID 0000-0002-5299-9106

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

adverse eventmyopathypersonalized therapypharmacogenetic burdenstatin intolerancestatins intensity

Identifiers

PMID41901359
PMCPMC13028775

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.